Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of LY3023414 in Japanese Patients with Advanced Malignancies
jRCT2080222989Phase 1
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of samotolisib in Nonhematologic neoplasms and solid tumor, sponsored by Eli Lilly and Company.
02
Drugs
samotolisib
03
Conditions
Nonhematologic neoplasmssolid tumor
Beyond the preview
Go deeper on jRCT2080222989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222989.